Cargando…
Penttinen syndrome‐associated PDGFRB Val665Ala variant causes aberrant constitutive STAT1 signalling
Penttinen syndrome is a rare progeroid disorder caused by mutations in platelet‐derived growth factor (PDGF) receptor beta (encoded by the PDGFRB proto‐oncogene) and characterized by a prematurely aged appearance with lipoatrophy, skin lesions, thin hair and acro‐osteolysis. Activating mutations in...
Autores principales: | Nédélec, Audrey, Guérit, Emilie M., Dachy, Guillaume, Lenglez, Sandrine, Wong, Lok San, Arts, Florence A., Demoulin, Jean‐Baptiste |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279580/ https://www.ncbi.nlm.nih.gov/pubmed/35689379 http://dx.doi.org/10.1111/jcmm.17427 |
Ejemplares similares
-
Letter to the editor: Regarding the editorial by Penttinen and Friede
por: Fry, Alicia M, et al.
Publicado: (2016) -
Author’s reply: Regarding the editorial by Penttinen and Friede
por: Penttinen, Pasi M, et al.
Publicado: (2016) -
Idiopathic basal ganglia calcification-associated PDGFRB mutations impair the receptor signalling
por: Arts, Florence A, et al.
Publicado: (2015) -
Unwanted acquired mutations in Ba/F3 transformation assays
por: Demoulin,, Jean-Baptiste, et al.
Publicado: (2017) -
Val-Gly-Val-Ala-Pro-Gly, a repeating peptide in elastin, is chemotactic for fibroblasts and monocytes
Publicado: (1984)